LinkedIn Profile

Access Inovio Pharmaceuticals historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:ino 117423 Apr 21st, 2024 12:00AM INOVIO Pharmaceuticals, Inc. 24K 222.00 Open Apr 20th, 2024 11:37PM Apr 20th, 2024 11:37PM INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. Our platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com. Open DNA medicines, DNA plasmids, HPV-associated disease, cancer, infectious diseases, coronaviruses, immuno-oncology, dMAb (DNA-encoded monoclonal antibodies), immunotherapy, DNA vaccines, high-risk HPV, cervical dysplasia, cervical cancer, cervical HSIL, vulvar HSIL, anal HSIL, recurrent respiratory papillomatosis (RRP), HPV-associated cancers, head and neck cancer, glioblastoma, prostate cancer, Ebola, Zika, MERS, COVID-19, HIV, Lassa, T cells, SynCon, CELLECTRA, and electroporation Open 660 West Germantown Pike, Suite 110 Plymouth Meeting PA US 19462 Inovio Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:ino 117423 Apr 20th, 2024 12:00AM INOVIO Pharmaceuticals, Inc. 24K 221.00 Open Apr 19th, 2024 11:35PM Apr 20th, 2024 05:09PM INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. Our platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com. Open DNA medicines, DNA plasmids, HPV-associated disease, cancer, infectious diseases, coronaviruses, immuno-oncology, dMAb (DNA-encoded monoclonal antibodies), immunotherapy, DNA vaccines, high-risk HPV, cervical dysplasia, cervical cancer, cervical HSIL, vulvar HSIL, anal HSIL, recurrent respiratory papillomatosis (RRP), HPV-associated cancers, head and neck cancer, glioblastoma, prostate cancer, Ebola, Zika, MERS, COVID-19, HIV, Lassa, T cells, SynCon, CELLECTRA, and electroporation Open 660 West Germantown Pike, Suite 110 Plymouth Meeting PA US 19462 Inovio Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:ino 117423 Apr 19th, 2024 12:00AM INOVIO Pharmaceuticals, Inc. 24K 221.00 Open Apr 18th, 2024 11:41PM Apr 18th, 2024 11:41PM INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. Our platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com. Open DNA medicines, DNA plasmids, HPV-associated disease, cancer, infectious diseases, coronaviruses, immuno-oncology, dMAb (DNA-encoded monoclonal antibodies), immunotherapy, DNA vaccines, high-risk HPV, cervical dysplasia, cervical cancer, cervical HSIL, vulvar HSIL, anal HSIL, recurrent respiratory papillomatosis (RRP), HPV-associated cancers, head and neck cancer, glioblastoma, prostate cancer, Ebola, Zika, MERS, COVID-19, HIV, Lassa, T cells, SynCon, CELLECTRA, and electroporation Open 660 West Germantown Pike, Suite 110 Plymouth Meeting PA US 19462 Inovio Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:ino 117423 Apr 18th, 2024 12:00AM INOVIO Pharmaceuticals, Inc. 24K 221.00 Open Apr 17th, 2024 11:50PM Apr 18th, 2024 06:30PM INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. Our platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com. Open DNA medicines, DNA plasmids, HPV-associated disease, cancer, infectious diseases, coronaviruses, immuno-oncology, dMAb (DNA-encoded monoclonal antibodies), immunotherapy, DNA vaccines, high-risk HPV, cervical dysplasia, cervical cancer, cervical HSIL, vulvar HSIL, anal HSIL, recurrent respiratory papillomatosis (RRP), HPV-associated cancers, head and neck cancer, glioblastoma, prostate cancer, Ebola, Zika, MERS, COVID-19, HIV, Lassa, T cells, SynCon, CELLECTRA, and electroporation Open 660 West Germantown Pike, Suite 110 Plymouth Meeting PA US 19462 Inovio Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:ino 117423 Apr 17th, 2024 12:00AM INOVIO Pharmaceuticals, Inc. 24K 221.00 Open Apr 16th, 2024 11:32PM Apr 17th, 2024 02:55PM INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. Our platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com. Open DNA medicines, DNA plasmids, HPV-associated disease, cancer, infectious diseases, coronaviruses, immuno-oncology, dMAb (DNA-encoded monoclonal antibodies), immunotherapy, DNA vaccines, high-risk HPV, cervical dysplasia, cervical cancer, cervical HSIL, vulvar HSIL, anal HSIL, recurrent respiratory papillomatosis (RRP), HPV-associated cancers, head and neck cancer, glioblastoma, prostate cancer, Ebola, Zika, MERS, COVID-19, HIV, Lassa, T cells, SynCon, CELLECTRA, and electroporation Open 660 West Germantown Pike, Suite 110 Plymouth Meeting PA US 19462 Inovio Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:ino 117423 Apr 16th, 2024 12:00AM INOVIO Pharmaceuticals, Inc. 24K 221.00 Open Apr 15th, 2024 11:28PM Apr 16th, 2024 11:11AM INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. Our platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com. Open DNA medicines, DNA plasmids, HPV-associated disease, cancer, infectious diseases, coronaviruses, immuno-oncology, dMAb (DNA-encoded monoclonal antibodies), immunotherapy, DNA vaccines, high-risk HPV, cervical dysplasia, cervical cancer, cervical HSIL, vulvar HSIL, anal HSIL, recurrent respiratory papillomatosis (RRP), HPV-associated cancers, head and neck cancer, glioblastoma, prostate cancer, Ebola, Zika, MERS, COVID-19, HIV, Lassa, T cells, SynCon, CELLECTRA, and electroporation Open 660 West Germantown Pike, Suite 110 Plymouth Meeting PA US 19462 Inovio Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:ino 117423 Apr 15th, 2024 12:00AM INOVIO Pharmaceuticals, Inc. 24K 221.00 Open Apr 14th, 2024 11:23PM Apr 15th, 2024 04:52PM INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. Our platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com. Open DNA medicines, DNA plasmids, HPV-associated disease, cancer, infectious diseases, coronaviruses, immuno-oncology, dMAb (DNA-encoded monoclonal antibodies), immunotherapy, DNA vaccines, high-risk HPV, cervical dysplasia, cervical cancer, cervical HSIL, vulvar HSIL, anal HSIL, recurrent respiratory papillomatosis (RRP), HPV-associated cancers, head and neck cancer, glioblastoma, prostate cancer, Ebola, Zika, MERS, COVID-19, HIV, Lassa, T cells, SynCon, CELLECTRA, and electroporation Open 660 West Germantown Pike, Suite 110 Plymouth Meeting PA US 19462 Inovio Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:ino 117423 Apr 14th, 2024 12:00AM INOVIO Pharmaceuticals, Inc. 24K 222.00 Open Apr 13th, 2024 11:12PM Apr 14th, 2024 11:11AM INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. Our platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com. Open DNA medicines, DNA plasmids, HPV-associated disease, cancer, infectious diseases, coronaviruses, immuno-oncology, dMAb (DNA-encoded monoclonal antibodies), immunotherapy, DNA vaccines, high-risk HPV, cervical dysplasia, cervical cancer, cervical HSIL, vulvar HSIL, anal HSIL, recurrent respiratory papillomatosis (RRP), HPV-associated cancers, head and neck cancer, glioblastoma, prostate cancer, Ebola, Zika, MERS, COVID-19, HIV, Lassa, T cells, SynCon, CELLECTRA, and electroporation Open 660 West Germantown Pike, Suite 110 Plymouth Meeting PA US 19462 Inovio Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:ino 117423 Apr 13th, 2024 12:00AM INOVIO Pharmaceuticals, Inc. 24K 222.00 Open Apr 12th, 2024 11:04PM Apr 13th, 2024 11:38AM INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. Our platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com. Open DNA medicines, DNA plasmids, HPV-associated disease, cancer, infectious diseases, coronaviruses, immuno-oncology, dMAb (DNA-encoded monoclonal antibodies), immunotherapy, DNA vaccines, high-risk HPV, cervical dysplasia, cervical cancer, cervical HSIL, vulvar HSIL, anal HSIL, recurrent respiratory papillomatosis (RRP), HPV-associated cancers, head and neck cancer, glioblastoma, prostate cancer, Ebola, Zika, MERS, COVID-19, HIV, Lassa, T cells, SynCon, CELLECTRA, and electroporation Open 660 West Germantown Pike, Suite 110 Plymouth Meeting PA US 19462 Inovio Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:ino 117423 Apr 12th, 2024 12:00AM INOVIO Pharmaceuticals, Inc. 24K 222.00 Open Apr 11th, 2024 11:09PM Apr 12th, 2024 08:33AM INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. Our platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com. Open DNA medicines, DNA plasmids, HPV-associated disease, cancer, infectious diseases, coronaviruses, immuno-oncology, dMAb (DNA-encoded monoclonal antibodies), immunotherapy, DNA vaccines, high-risk HPV, cervical dysplasia, cervical cancer, cervical HSIL, vulvar HSIL, anal HSIL, recurrent respiratory papillomatosis (RRP), HPV-associated cancers, head and neck cancer, glioblastoma, prostate cancer, Ebola, Zika, MERS, COVID-19, HIV, Lassa, T cells, SynCon, CELLECTRA, and electroporation Open 660 West Germantown Pike, Suite 110 Plymouth Meeting PA US 19462 Inovio Pharmaceuticals Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.